![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EX-GUIDANT EXEC WILL LEAD BRISTOL-MYERS
EX-GUIDANT EXEC WILL LEAD BRISTOL-MYERS
Jim Cornelius, who built a long career in executive positions at Eli Lilly and Co. and Guidant Corp., has been named interim chief executive of Bristol-Myers Squibb after the drug maker ousted CEO Peter R. Dolan over a soured patent agreement for its blockbuster drug Plavix.
Indianapolis
Star
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct